Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

An automated solid-phase extraction (SPE) method has been developed to detect cyanotoxins in water. A team of scientists from Friedrich Schiller University Jena and Analytik Jena both in Jena, Germany ...

Therapeutic peptides like semaglutide and tirzepatide, GLP-1 agonists marketed under brand names such ... known as solid-phase peptide synthesis (SPPS) relies on resource-intensive chemical synthesis ...

Sai Life Sciences, a Contract Research, Development, and Manufacturing Organisation (CRDMO), set up a dedicated Peptide Research Center at its integrated R&D Campus here. “As the pharmaceutical ...

The landscape of drug discovery is evolving rapidly, driven by breakthroughs in AI, high-throughput screening and precision medicine. As researchers work to develop safer, more effective therapies, ...

Leveraging genetic recombination technology, research teams have ingeniously fused FGF21 with cell-penetrating peptides (CPPs ... this recombinant FGF21 protein has been shown to simplify purification ...

ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP ... on skin health. GLP-1 receptor agonists are effective at inducing fat loss in patients with obesity and type 2 diabetes, but their ...

ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP ... on skin health. GLP-1 receptor agonists are effective at inducing fat loss in patients with obesity and type 2 diabetes, but their ...